Stockscreener 앱 받기
1.58
6.51%
-0.11
시장 영업 전:
1.60
0.02
+1.27%
Enlivex Ltd 주식(ENLV)의 최신 뉴스
Enlivex Ltd. SEC Filing (Aug 14, 2026) - Stock Titan
Enlivex Ltd. (ENLV) sees 9.99% stake reported via convertible note - Stock Titan
Enlivex Restructures $19.2 Million Convertible Note With Lind, Easing Default Risk - TipRanks
Enlivex (ENLV) revises $21M secured convertible note, adds 10% interest trigger - Stock Titan
Enlivex Therapeutics Ltd (ENLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
ENLV Stockholders Plan Sale of 10 Million Shares Amidst Challenging Valuation Landscape - GuruFocus
Enlivex Ltd. (NASDAQ: ENLV) files to register 10M shares for noteholder resale - Stock Titan
Enlivex (ENLV) Climbs 3.83% to $2.17 as Shares Press Against $2.28 ResistanceVolume Spike Alerts - dars.gov.et
ENLV Maintained by HC Wainwright & Co. -- Price Target Raised to $80 - GuruFocus
H.C. Wainwright Lifts Enlivex Therapeutics (ENLV) Price Target t - GuruFocus
H.C. Wainwright raises Enlivex stock price target to $80 on token gains - Investing.com
Weekly Recap: HC Wainwright & Co. PT hike and Rain Foundation financing - TradingView
Enlivex Therapeutics Ltd (ENLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June - marketscreener.com
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones - marketscreener.com
Enlivex Ltd. announced that it expects to receive $400 million in funding - marketscreener.com
Enlivex prices USD 400 million private placement at USD 5 per share - Bitget
Enlivex: Price Is $5/Shr for Subscription Amounts Funded in U.S. Dollars, USDT or USD Coin >ENLV - Moomoo
ENLV Stock Slides Into 1-For-15 Reverse Split On Nasdaq - StocksToTrade
Enlivex (ENLV) Secures $400M Private Placement at Premium Pricing - GuruFocus
Enlivex Secures $400 Million Premium-Priced Private Placement Backed by RAIN Tokens - TipRanks
Enlivex Announces $400,000,000 Private Placement - marketscreener.com
Enlivex (Nasdaq: ENLV) sets $400M RAIN token-linked private placement - Stock Titan
Enlivex investor may fund proposed $400M deal with RAIN tokens - Stock Titan
ENLV|Enlivex Therapeutics Ltd|Price:4.250|Chg%:+0.050 - TradingKey
Enlivex Therapeutics Ltd (ENLV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enlivex Market Sentiment - Benzinga España
Enlivex Therapeutics Ltd (ENLV) Balance Sheet - TradingKey
Enlivex Therapeutics Ltd (ENLV) Cash Flow - TradingKey
Enlivex Therapeutics Ltd (ENLV) Income Statement - TradingKey
Enlivex Therapeutics Ltd (ENLV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enlivex Therapeutics Ltd (ENLV) Institutional Confidence - TradingKey
Enlivex Therapeutics Ltd (ENLV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Enlivex(ENLV) Stock Options Chain | Quotes & News - Moomoo
Enlivex Therapeutics Ltd (ENLV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enlivex Ltd (1BT.DU) latest press releases and corporate news - Yahoo Finance UK
Short Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Declines By 98.2% - MarketBeat
Enlivex Therapeutics (NASDAQ:ENLV) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Enlivex Ltd (1BT.DU) stock price, news, quote and history - Yahoo Finance UK
Enlivex Ltd. (ENLV) Q4 2025 Earnings: Massive EPS Discrepancy Reflects Non-Recurring Charges; Pipeline Progress ContinuesPreliminary Results - dars.gov.et
Enlivex Ltd. (ENLV) Posts Modest Gains as Shares Consolidate Near SupportRisk Reward Setups - dars.gov.et
Enlivex Reveals $1.1 Billion RAIN Token Treasury and $66.16 NAV Per Share - The Globe and Mail
Enlivex Ltd. (ENLV) Rallies 1.71% – Testing Key Resistance at $5.0RVOL Spike - dars.gov.et
Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion - The Manila Times
Enlivex (Nasdaq: ENLV) details $1.1B RAIN token holdings and NAV - Stock Titan
Enlivex’s Net Asset Value Per Share Was $66.16 on July 18 - Stock Titan
Enlivex Ltd. (ENLV) upgraded to buy: Here's why - MSN
Enlivex (ENLV) Receives RMAT Designation for Knee Osteoarthritis Treatment - GuruFocus
Enlivex Wins FDA RMAT Status for Allocetra in Age-Related Knee Osteoarthritis - TipRanks
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why - Yahoo Finance
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
FDA grants regenerative medicine designation to Enlivex therapy By Investing.com - Investing.com South Africa
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis - The Manila Times
FDA grants regenerative medicine designation to Enlivex therapy - Investing.com
Enlivex (ENLV) wins FDA RMAT designation for Allocetra in age-related knee osteoarthritis - Stock Titan
FDA flags Enlivex’s Allocetra as potential new option for painful knee osteoarthritis - Stock Titan
Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA - Investing.com Canada
Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA By Investing.com - Investing.com South Africa
Should I buy Enlivex Ltd. (ENLV) - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Tranche Update on Enlivex Therapeutics Ltd.'s Equity Buyback Plan announced on September 18, 2023. - marketscreener.com
Enlivex: Performance & Quotes, ENLV Stock Price on Nasdaq Exchange - marketscreener.com
0.52%
0.07%
자본화:
|
볼륨(24시간):